Malaysia
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1.60
|
Dec. 31, 2023 | USD 0.51 | -1.32% |
|
Malaysia |
|
2 |
0.80
|
Dec. 31, 2023 | USD 0.27 | -1.64% |
|
Malaysia |
|
3 |
0.65
|
May 31, 2024 | USD 0.22 | -0.04% |
|
Malaysia |
|
4 |
0.10
|
Dec. 31, 2023 | USD 1.35 | -31.47% |
|
Malaysia |
|
5 |
0.07
|
Aug. 31, 2024 | USD 0.27 | -0.87% |
|
Malaysia |
|
6 |
0.07
|
March 31, 2024 | USD 3.29 | -0.45% |
|
Malaysia |
|
7 |
0.03
|
June 30, 2024 | USD 0.25 | -1.78% |
|
Malaysia |
|
8 |
0.02
|
March 31, 2024 | USD 0.80 | -0.04% |
|
Malaysia |
|
9 |
0.00
|
June 30, 2024 | USD 0.94 | -2.12% |
|
Malaysia |
The Pharmaceuticals company in Malaysia with the highest Debt to Equity Ratio is KPJ Healthcare Berhad (Kuala Lumpur Stock Exchange: 5878.KL) at 1.60.
The Pharmaceuticals company in Malaysia with the lowest Debt to Equity Ratio is Kotra Industries Berhad (Kuala Lumpur Stock Exchange: 0002.KL) at 0.00.
The top 10 Pharmaceuticals companies in Malaysia by Debt to Equity Ratio are KPJ Healthcare Berhad, Duopharma Biotech Berhad, Ancom Nylex Berhad, Agape ATP Corporation, Top Glove Corporation Bhd., Ajinomoto (Malaysia) Bhd, Supermax Corporation Berhad, Hartalega Holdings Berhad and Kotra Industries Berhad.
The bottom 10 Pharmaceuticals companies in Malaysia by Debt to Equity Ratio are Kotra Industries Berhad, Hartalega Holdings Berhad, Supermax Corporation Berhad, Ajinomoto (Malaysia) Bhd, Top Glove Corporation Bhd., Agape ATP Corporation, Ancom Nylex Berhad, Duopharma Biotech Berhad and KPJ Healthcare Berhad.